On demand webcasts

Our dedicated webcast channel featuring on-demand presentations and Q&A sessions from our investment professionals.

Strategic Bond – Quarterly Update

Join John Pattullo and Jenna Barnard, Co-Head of Global Bonds, for this final quarterly update as they explore developments in the economy, the latest moves in rates, the pressures building in credit markets and what this is likely to mean for bond investors.

European Small Companies – Strategy Update

Please join Richard Brown, Client Portfolio Manager, who will provide an update on Global and European Smaller Companies, sharing the latest market perspectives and outlook.
The webcast will include an update on positioning and performance.

Multi Sector Income – Fund Update

Join John Kerschner and John Lloyd, who will provide an update on the Multi Sector Income fund, sharing their latest market perspectives and outlook.

Strategic Bond Update

If you were able to attend, we hope you found it informative. In case you missed it, or would like to review anything, be sure to check out the replay.

Investing in the next wave of innovative medicines

In our latest panel discussion portfolio manager Andy Acker, research analyst Agustin Mohedas, scientist Dr. Stephen Harrison and Akero’s CEO Andrew Cheng, detailed the remarkable advances in disease categories that previously had limited treatment options, like NASH, a severe form of nonalcoholic fatty liver disease.

Balancing wealth transfer across generations

In this webinar, Ben Rizzuto, Retirement Director and Jeremiah Buckley, co-Portfolio Manager of the Janus Henderson Balanced Fund, will discuss how financial advisors should position their business for this new generation of investors, ways they can engage with families across generations, and why a Balanced portfolio may be best suited for them.

Brighter days ahead for listed property

Guy Barnard, Co-Head Global Property Equities and Matthew Bullock, EMEA Head of Portfolio Construction & Strategy, as they discuss these attributes and which subsectors are best positioned to continue to deliver earnings and dividend growth, even as economies slow.

A dose of immunity during a market downturn

Accelerating innovation in the biotechnology sector may offer investors new potential growth opportunities. In a market environment where we believe investors should tread carefully, Jennifer Nichols, Client Portfolio Manager and Matthew Bullock, EMEA Head of Portfolio Construction and Strategy discussed how healthcare’s unique blend of defensive characteristics and growth potential may offer immunity from the downturn.